DE60012301D1 - Lipoproteinkomplexe und zusammensetzungen, die diese enthalten - Google Patents

Lipoproteinkomplexe und zusammensetzungen, die diese enthalten

Info

Publication number
DE60012301D1
DE60012301D1 DE60012301T DE60012301T DE60012301D1 DE 60012301 D1 DE60012301 D1 DE 60012301D1 DE 60012301 T DE60012301 T DE 60012301T DE 60012301 T DE60012301 T DE 60012301T DE 60012301 D1 DE60012301 D1 DE 60012301D1
Authority
DE
Germany
Prior art keywords
complexes
compositions
compositions containing
component
lipoprotein complexes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60012301T
Other languages
English (en)
Inventor
Benvenuto Cestaro
Elvira Pistolesi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hunza Di Pistolesi Elvira & C
Original Assignee
Hunza Di Pistolesi Elvira & C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT1999MI000114 external-priority patent/IT1307917B1/it
Priority claimed from IT1999MI002471 external-priority patent/IT1313688B1/it
Application filed by Hunza Di Pistolesi Elvira & C filed Critical Hunza Di Pistolesi Elvira & C
Application granted granted Critical
Publication of DE60012301D1 publication Critical patent/DE60012301D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J7/00—Phosphatide compositions for foodstuffs, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Polymers & Plastics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DE60012301T 1999-01-22 2000-01-21 Lipoproteinkomplexe und zusammensetzungen, die diese enthalten Expired - Lifetime DE60012301D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT1999MI000114 IT1307917B1 (it) 1999-01-22 1999-01-22 Complessi lipoproteici e composizioni che li contengono.
IT1999MI002471 IT1313688B1 (it) 1999-11-26 1999-11-26 Complessi lipoproteici e composizioni che li contengono.
PCT/EP2000/000452 WO2000043036A2 (en) 1999-01-22 2000-01-21 Lipoprotein complexes and compositions containing them

Publications (1)

Publication Number Publication Date
DE60012301D1 true DE60012301D1 (de) 2004-08-26

Family

ID=26331634

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60012301T Expired - Lifetime DE60012301D1 (de) 1999-01-22 2000-01-21 Lipoproteinkomplexe und zusammensetzungen, die diese enthalten

Country Status (9)

Country Link
US (1) US6340669B1 (de)
EP (1) EP1143999B1 (de)
JP (1) JP2002535288A (de)
KR (1) KR20010101594A (de)
AT (1) ATE271392T1 (de)
AU (1) AU2542500A (de)
CA (1) CA2360065A1 (de)
DE (1) DE60012301D1 (de)
WO (1) WO2000043036A2 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936289B2 (en) 1995-06-07 2005-08-30 Danisco A/S Method of improving the properties of a flour dough, a flour dough improving composition and improved food products
JP3599347B2 (ja) 1995-09-06 2004-12-08 協和醗酵工業株式会社 脂質代謝改善剤
GB9921229D0 (en) * 1999-09-08 1999-11-10 Med Eq As Compositions
EP1225814B1 (de) * 1999-10-29 2005-04-27 Hunza di Pistolesi Elvira E C. S.a.S. Faserige lipo-ernährungskomplexe und diese enthaltende zusammensetzungen
BR0112799B1 (pt) 2000-07-28 2017-10-24 Hoffmann La Roche Pharmaceutical composition, process for the preparation of the same, use of a lipase inhibitor and a bilic acid sequestrant
IT1320180B1 (it) * 2000-12-29 2003-11-26 Hunza Di Marazzita Maria Carme Preparazioni nutrizionali e terapeutiche dotate di attivita'antiossidante ed in grado di controllare gli eccessi ponderali e
ITMI20010141A1 (it) * 2001-01-26 2002-07-26 Giuliani Spa Procedimento per la preparazione di composizioni farmaceutiche o dietetiche per la veicolazione nell'intestino di sostanze labili
MXPA03010511A (es) 2001-05-18 2004-03-02 Danisco Metodo para preparar una masa con una enzima.
US6797287B2 (en) 2001-09-25 2004-09-28 Pharmachem Laboratories, Inc. Phaseolamin compositions and methods for using the same
US20030165574A1 (en) * 2002-03-01 2003-09-04 Ward Loren Spencer Compositions and methods for treatment of body weight conditions
US7790670B2 (en) * 2002-03-01 2010-09-07 Glanbia Nutritionals (Ireland) Ltd. Compositions and methods for treatment of body weight conditions
EP1551431A4 (de) * 2002-06-28 2005-11-30 Pharmachem Lab Inc Gereinigter amylase-inhibitor und neuartiges verfahren zu seiner herstellung
US7108869B2 (en) * 2002-11-07 2006-09-19 Access Business Group International Llc Nutritional supplement containing alpha-glucosidase and alpha-amylase inhibitors
NZ550944A (en) * 2004-04-02 2009-12-24 Univ Tennessee Res Foundation Dairy components effective for fat loss
US20050244367A1 (en) * 2004-05-03 2005-11-03 Ilypsa, Inc. Phospholipase inhibitors localized in the gastrointestinal lumen
CN102277231A (zh) 2004-07-16 2011-12-14 丹尼斯科公司 用酶使油脱胶的方法
AU2006235407B2 (en) * 2005-04-11 2011-02-24 University Of Tennessee Research Foundation Stable dairy components effective for fat loss
CN101678039A (zh) * 2006-12-07 2010-03-24 本巴科技2006有限公司 采用疏水性微米微粒的用于减少胆固醇的混合物与方法
US10117885B2 (en) * 2011-08-11 2018-11-06 Allergy Research Group, Llc Chewable lipid supplements for treating pain and fibromyalgia
US9290752B2 (en) 2013-03-13 2016-03-22 Sunny Delight Beverages Co. Process for enhancing the amylase inhibitory efficacy from phaseolus vulgaris extracts

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2400518A1 (de) * 1974-01-07 1975-07-10 Ritter & Co D Diaetetische zubereitung
JP2960947B2 (ja) 1989-12-25 1999-10-12 日清製粉株式会社 脂質分解酵素阻害剤
JPH03291229A (ja) * 1990-04-06 1991-12-20 Kyodo Nyugyo Kk アミラーゼインヒビターによる肥満の治療及びその予防法
TW381025B (en) 1993-08-05 2000-02-01 Hoffmann La Roche Pharmaceutical composition containing a glucosidase inhibitor and a lipase inhibitor
DE29708250U1 (de) * 1997-05-07 1997-07-10 Meyer Lucas Gmbh & Co Brotaufstrich mit cholesterinspiegelsenkender Wirkung

Also Published As

Publication number Publication date
JP2002535288A (ja) 2002-10-22
WO2000043036A2 (en) 2000-07-27
AU2542500A (en) 2000-08-07
EP1143999B1 (de) 2004-07-21
EP1143999A3 (de) 2002-09-11
US6340669B1 (en) 2002-01-22
WO2000043036A3 (en) 2001-11-01
EP1143999A2 (de) 2001-10-17
ATE271392T1 (de) 2004-08-15
KR20010101594A (ko) 2001-11-14
CA2360065A1 (en) 2000-07-27

Similar Documents

Publication Publication Date Title
DE60012301D1 (de) Lipoproteinkomplexe und zusammensetzungen, die diese enthalten
ATE383169T1 (de) Komponente und zusammensetzungen zur verabreichung von wirkstoffen
AU4871797A (en) Magnesium (-)hydroxycitrate, preparation process, uses and compositions, in particular pharmaceutical compositions, containing it
HUP9901144A2 (hu) Hatóanyagként klopidogrel és egy antitrombotikum új kombinációját tartalmazó gyógyszerkészítmények
FR2805465B1 (fr) Nouvelles compositions pharmaceutique ou dietetiques a base de champignons
IL154318A0 (en) Pharmaceutical compositions for the treatment of movement disorders
ID28598A (id) Komposisi-komposisi yang mengandung vitamin-vitamin yang dapat larut lemak
EE200000054A (et) Vitamiini D ja kaltsiumit sisaldav ravimkoostis, selle valmistamine ja terapeutiline kasutamine
CY1108138T1 (el) Χρησιμοποιηση λουπινοκονγλουτινης δια την θεραπευτικη αγωγη διαβητου τυπου ιι
AU1275401A (en) Fibrous-liponutritional complexes and compositions containing them
ES2195902T3 (es) Composicion que comprende esfingomielinasa alcalina para uso como preparacion dietetica, complemento alimenticio o producto farmaceutico.
BRPI0309421A8 (pt) Método de preparar um gênero alimentício e composição para tratar ou prevenir hipercolesterolemia
DE60020738D1 (de) Teilchenförmige vitaminzubereitung
CA2388910A1 (en) Antimicrobial activity of the first cationic cluster of human lactoferrin
TR200003737T1 (tr) Diyet takviyesi ya da ilaç olarak kullanılan bileşim
GB2379855A (en) Dietary regime for companion animals
AU5634500A (en) Dietary calcium as a supplement to vitamin d compound treatment of multiple sclerosis
MXPA02011465A (es) Sal de creatina que tiene eficacia terapeutica y nutricional mejorada y composiciones que contienen la misma.
ATE381944T1 (de) Injizierbare arzneimittel die ein anthracendionderivat, mit antitumoraktivität, enthalten
ZA9711734B (en) Novel farnesyl transferase inhibitors, their preparation, the pharmaceutical compositions which contain them and their use in the preparation of medicaments.
DK1497250T3 (da) Hyperforinderivater, anvendelse heraf og sammensætninger indeholdende disse
AU5284999A (en) New injectable formulations containing ramoplanin
UA32262A (uk) Зубна паста
ITMI990597A0 (it) Composizioni farmaceutiche dietetiche o alimenti funzionali ad attivita' antiossidante
ITMI981512A1 (it) Composizioni farmaceutiche, dietetiche o alimenti funzionali ad attivita' antiossidante

Legal Events

Date Code Title Description
8332 No legal effect for de